- Business Wire•13 hours ago
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces Securities Class Action Lawsuit against DaVita Inc. and Encourages Investors with Losses to Contact the Firm
Khang & Khang LLP announces a class action lawsuit against DaVita Inc. . Investors who purchased or otherwise acquired shares between August 5, 2015 and October 21, 2016, inclusive , are encouraged to contact the Firm in advance of the April 3, 2017 lead plaintiff motion deadline.
- Reuters•15 hours ago
Kidney dialysis company DaVita, Inc has won antitrust approval to buy rival Renal Ventures Management LLC on condition that it sell five clinics, the Federal Trade Commission said on Tuesday. The clinics ...
- GlobeNewswire•15 hours ago
DVA INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving DaVita Inc. and a Lead Plaintiff Deadline of April 3, 2017
NEW YORK, March 28, 2017-- The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of Colorado on behalf of investors who purchased DaVita Inc. ...
DVA : Summary for DaVita Inc. Common Stock - Yahoo Finance
DaVita Inc. (DVA)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||66.59 - 67.85|
|52 Week Range||54.50 - 78.77|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||15.78|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|